We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Predicting Age by Profiling Circulating Plasma Proteins

By LabMedica International staff writers
Posted on 16 Dec 2019
Print article
Image: Representation of the structure of human serum albumin, the most abundant protein in human blood plasma (Photo courtesy of Wikimedia Commons)
Image: Representation of the structure of human serum albumin, the most abundant protein in human blood plasma (Photo courtesy of Wikimedia Commons)
It has been shown to be possible to calculate the age of an individual by measuring levels of various proteins circulating in the blood plasma.

Aging is a predominant risk factor for several chronic diseases that limit longevity, and mechanisms that regulate aging have become increasingly recognized as potential therapeutic targets.

To evaluate biochemical factors linked to aging, investigators at Stanford University (Palo Alto, CA, USA) measured 2,925 plasma proteins from 4,263 young adults to nonagenarians (18–95 years old). Some of the samples came from the LonGenity study, which had accumulated blood samples from a cohort of exceptionally long-lived Ashkenazi Jews.

The investigators measured the levels of roughly 3,000 proteins in plasma samples from each individual. Results revealed 1,379 proteins with levels that varied significantly with participants' age. By employing a new bioinformatics approach that uncovered marked non-linear alterations in the human plasma proteome with age, the investigators were able to define a reduced set of 373 proteins that was sufficient to predict participants' ages with considerable accuracy.

The investigators also discovered waves of changes in the distribution of plasma proteins in the fourth, seventh, and eighth decades of life (roughly at ages 34, 60, and 78), which reflected distinct biological pathways and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits.

"We have known for a long time that measuring certain proteins in the blood can give you information about a person's health status - lipoproteins for cardiovascular health, for example," said senior author Dr. Tony Wyss-Coray, professor of neurology and neurological sciences, at Stanford University. "But it has not been appreciated that so many different proteins' levels - roughly a third of all the ones we looked at - change markedly with advancing age."

The study was published in the December 5, 2019, online edition of the journal Nature Medicine.

Related Links:
Stanford University

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Centromere B Assay
Centromere B Test

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.